Actual Medicinal Product (AMP) Methotrexate 2.5mg tablets (Cipla EU Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
Medicines under this category are not suitable for use inside MCAs.
Notes

Tablets are cytotoxic. Not recommended due to handler risk.

Generic
Methotrexate
Formulation
Methotrexate 2.5mg tablets
  • Methotrexate
    • Methotrexate 2.5mg tablets

      • Methotrexate 2.5mg tablets (Cipla EU Ltd)

Alternative Suppliers (18)

Methotrexate 2.5mg tablets (A A H Pharmaceuticals Ltd)
Maxtrex 2.5mg tablets (Pfizer Ltd)
Methotrexate 2.5mg tablets (Alliance Healthcare (Distribution) Ltd)
Methotrexate 2.5mg tablets (Advanz Pharma)
Methotrexate 2.5mg tablets (Sigma Pharmaceuticals Plc)
Methotrexate 2.5mg tablets (Orion Pharma (UK) Ltd)
Methotrexate 2.5mg tablets (Sandoz Ltd)
Methotrexate 2.5mg tablets (Teva UK Ltd)
Methotrexate 2.5mg tablets (Morningside Healthcare Ltd)
Methotrexate 2.5mg tablets (DE Pharmaceuticals)
Methotrexate 2.5mg tablets (Almus Pharmaceuticals Ltd)
Methotrexate 2.5mg tablets (Medihealth (Northern) Ltd)
Methotrexate 2.5mg tablets (Cipla EU Ltd)
Methotrexate 2.5mg tablets (Pfizer Ltd)
Methotrexate 2.5mg tablets (Kent Pharma (UK) Ltd)
Methotrexate 2.5mg tablets (Wockhardt UK Ltd)
Methotrexate 2.5mg tablets (Waymade Healthcare Plc)
Methotrexate 2.5mg tablets (Mawdsley-Brooks & Company Ltd)